Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07416526

A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

Conditions: Hemophilia A

Sex: All

Ages: 12 Years – N/A

Healthy volunteers: No

Phase: PHASE3

Enrollment: 126

Sponsor: Hoffmann-La Roche

Location: University of Colorado Hemophilia and Thrombosis Center Aurora Colorado

Summary

The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of NXT007 prophylaxis compared with Factor VIII (FVIII) prophylaxis in participants with severe or moderate congenital hemophilia A without inhibitors. The study will include people aged ≥12 years old with severe or moderate congenital hemophilia A without inhibitors on previous FVIII prophylaxis treatment.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of severe (FVIII:C \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07416526). StuddyBuddy aggregates publicly available trial information.